Viewing Study NCT00698906


Ignite Creation Date: 2025-12-26 @ 2:38 PM
Ignite Modification Date: 2025-12-26 @ 2:38 PM
Study NCT ID: NCT00698906
Status: COMPLETED
Last Update Posted: 2008-06-17
First Post: 2008-06-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module